Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share of Common Stock (Tables)

v3.24.3
Loss Per Share of Common Stock (Tables)
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
The following tables are a reconciliation of the numerators and denominators used in the calculation of basic and diluted net loss per share computations:
Three Months Ended
September 30, (Unaudited)
Nine Months Ended
September 30, (Unaudited)
2024 2023 2024 2023
Basic EPS and diluted EPS:
Loss (Numerator)
Net loss $ (3,898,297) $ (24,945,834) $ (16,820,644) $ (33,224,854)
Shares (Denominator)
Weighted average common shares outstanding, including shares issuable upon the exercise of pre-funded warrants
38,819,387  7,880,546  35,317,352  5,207,411 
Per-Share Amount $ (0.10) $ (3.17) $ (0.48) $ (6.38)
Schedule of anti-dilutive securities
The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been anti-dilutive:
Three Months Ended
September 30, (Unaudited)
Nine Months Ended
September 30, (Unaudited)
2024 2023 2024 2023
Stock options 1,639,354  442,803  1,639,354  442,803 
Warrants 3,272,940  3,280,940  3,272,940  3,280,940 
Unvested restricted stock units
513,446  843,110  513,446  843,110 
Common shares underlying convertible debt
—  980,673  —  980,673